My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

23.86 +0.63 (+2.71%)
Official Closing Price Updated: 7:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Baxter (NYSE:BAX) Beats Q4 Sales Targets, Stock Soars
Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $2.75 billion. On the other hand, next quarter’s revenue... 
Via StockStory
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
From Baxter International Inc.
Via Business Wire
Earnings Scheduled For February 20, 2025
 
Via Benzinga
Baxter Earnings: What To Look For From BAX
Healthcare company Baxter International (NYSE:BAX) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Baxter to Present at TD Cowen 45th Annual Health Care Conference
From Baxter International Inc.
Via Business Wire
Earnings Scheduled For February 13, 2025
 
Via Benzinga
How Is The Market Feeling About Baxter Intl?
 
Via Benzinga
Uncovering Potential: Baxter Intl's Earnings Preview
 
Via Benzinga
Baxter to Present at Raymond James & Associates’ 46th Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day
From Baxter International Inc.
Via Business Wire
What To Expect From Baxter’s (BAX) Q4 Earnings
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft. 
Via Benzinga
Baxter Announces CEO Retirement and Appointment of COO
From Baxter International Inc.
Via Business Wire
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
From Vantive
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Confidence Is Just As Dangerous When It's Too Low As When It's Too High
To attain goals, you need confidence. It takes self-assurance to pursue what matters most to you. But too much confidence has risks, too. 
Via Investor's Business Daily
Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Puerto Rico Blackout: 8 Stocks Affected By Island-Wide Power Outage
Only around 12% of Puerto Rico's residents currently have electricity, according to Luma Energy, the power company servicing the island. 
Via Benzinga
“Healthcare Left For Dead” Stock Market (And Sentiment Results)
This afternoon felt like either a fund blew up or the margin clerks were taking a bunch of dumb over-leveraged money out to the woodshed to put them out of their misery. 
Via Talk Markets
Topics Stocks / Equities
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Baxter International Inc.
Via Business Wire
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.
From Baxter International Inc.
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Baxter International: Dividend Cut Because Of Restructuring
Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow. 
Via Talk Markets
Topics Stocks / Equities
Baxter to Present at 7th Annual Evercore HealthCONx Conference
From Baxter International Inc.
Via Business Wire
Baxter to Present at Jefferies London Healthcare Conference
From Baxter International Inc.
Via Business Wire
Baxter to Present at Stifel 2024 Healthcare Conference
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook
Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management. 
Via Benzinga
Topics Economy
Baxter Reports Third-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.